The utilization of Quality-Adjusted Life Years (QALYs) metrics to determine the cost-effectiveness of the development, delivery, and detriment of medications, operations, and other health interventions may result in unacceptable long-term impacts on people living with disabilities or chronic illnesses, including HIV, Rheumatoid Arthritis, and other long-term illnesses that are expensive to treat.

QALYS are very likely fueling health disparities. Read why here…